Marex Group plc (MRX) Key Metrics
MRX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.35B
- Enterprise value
- $8.23B
- P/E (TTM)
- 14.2
- Forward P/E
- 7.2
- PEG ratio
- —
- Price / sales
- 1.2
- Price / book
- 2.8
- EV / EBITDA
- 5.6
- Dividend yield
- 0.86% $0.64 a year
- Beta
- −0.02
MRX key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsMRX valuation Price multiples at each fiscal year-end price.
MRX returns How much profit the business earns on the capital it uses.
MRX per-share figures Results divided by the shares outstanding at year-end.
MRX financial health Debt, liquidity and how easily interest is covered.
MRX efficiency & capital use Working capital cycle and where the cash goes.
MRX valuation history
MRX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
MRX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
MRX cash returned to shareholders
MRX price vs earnings per share
MRX key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.92B | $2.35B | — | — | — | — | — | — | — | — |
| Enterprise value | −$301.4M | $3.27B | — | — | — | — | — | — | — | — |
| P/E ratio | 9.5 | 10.8 | — | — | — | — | — | — | — | — |
| Price / sales | 0.8 | 0.8 | — | — | — | — | — | — | — | — |
| Price / book | 2.3 | 2.4 | — | — | — | — | — | — | — | — |
| Price / free cash flow | 4.5 | 2.1 | — | — | — | — | — | — | — | — |
| Price / operating cash flow | 4.4 | 2.0 | — | — | — | — | — | — | — | — |
| EV / sales | -0.1 | 1.1 | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | 3.8 | — | — | — | — | — | — | — | — |
| EV / free cash flow | — | 2.9 | — | — | — | — | — | — | — | — |
| Earnings yield | 10.6% | 9.3% | — | — | — | — | — | — | — | — |
| Free cash flow yield | 22.4% | 48.7% | — | — | — | — | — | — | — | — |
| Dividend yield | 1.9% | 3.3% | — | — | — | — | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 3.4% | 4.1% | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $38.36 | $31.17 | — | — | — | — | — | — | — | — |
| Per share | ||||||||||
| Revenue per share | $47.68 | $38.45 | $32.57 | $16.60 | $12.03 | $12.49 | $9.06 | $6.34 | $5.24 | $5.41 |
| Earnings per share | $4.05 | $2.90 | $1.77 | $1.29 | $0.80 | $0.72 | $0.60 | $0.17 | $0.29 | $0.34 |
| Operating cash flow per share | $8.77 | $15.46 | $10.18 | $3.19 | $6.65 | −$0.76 | −$0.38 | $2.15 | −$1.58 | $0.50 |
| Free cash flow per share | $8.60 | $15.19 | $10.01 | $3.05 | $6.54 | −$0.81 | −$0.43 | $2.13 | −$1.60 | $0.48 |
| Cash per share | $176.77 | $69.26 | $65.53 | $45.49 | $10.71 | $4.81 | $3.59 | $2.65 | $1.47 | $3.10 |
| Book value per share | $16.60 | $12.98 | $10.74 | $9.57 | $6.75 | $7.32 | $6.89 | $6.30 | $6.14 | $6.17 |
| Tangible book value per share | $12.20 | $9.88 | $7.70 | $7.01 | $3.49 | $3.81 | $3.81 | $3.94 | $3.80 | $3.83 |
| Dividends per share | $0.73 | $1.02 | $0.81 | $0.09 | $0.28 | $0.30 | — | — | $0.33 | $0.33 |
| Capex per share | $0.17 | $0.26 | $0.17 | $0.13 | $0.10 | $0.06 | $0.05 | $0.02 | $0.03 | $0.02 |
| Debt per share | $134.45 | $81.56 | $74.60 | $80.90 | $18.22 | $4.07 | $0.21 | — | — | — |
| Shares outstanding | 76.1M | 75.3M | 72.2M | 70.8M | 70.8M | 60.6M | 60.6M | 60.6M | 60.6M | 60.6M |
| Change in shares outstanding | +1.1% | +4.2% | +2.0% | 0.0% | +16.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 27.5% | 24.9% | 17.6% | 15.9% | 12.3% | 10.2% | 9.1% | 2.7% | 4.7% | 5.5% |
| Return on invested capital (ROIC) | — | 37.0% | 21.3% | 10.4% | 7.9% | 14.7% | 4.4% | 13.6% | 7.4% | 10.0% |
| Return on assets (ROA) | 1.0% | 1.0% | 0.8% | 0.9% | 1.3% | 1.4% | 1.8% | 0.8% | 1.6% | 1.8% |
| Return on tangible assets | 0.9% | 0.9% | 0.7% | 0.6% | 1.1% | 1.2% | 1.5% | 0.8% | 1.9% | 2.1% |
| Free cash flow margin | 18.0% | 39.5% | 30.7% | 18.4% | 54.4% | −6.5% | −4.7% | 33.6% | −30.6% | 8.8% |
| Income quality (OCF / net income) | 2.17 | 5.34 | 5.74 | 2.46 | 8.33 | −1.04 | −0.64 | 12.83 | −5.46 | 1.47 |
| Financial health | ||||||||||
| Total debt | $10.23B | $6.14B | $5.39B | $5.73B | $1.29B | $246.8M | $12.9M | — | — | — |
| Cash & short-term investments | $13.46B | $5.21B | $4.73B | $3.22B | $758.3M | $291.5M | $217.5M | $160.7M | $89.2M | $188.2M |
| Net debt | −$3.22B | $926.2M | $654.8M | $2.51B | $531.8M | −$44.8M | −$204.6M | −$160.7M | −$89.2M | −$188.2M |
| Debt / equity | 8.10 | 6.28 | 6.94 | 8.45 | 2.70 | 0.56 | 0.03 | — | — | — |
| Debt / assets | 0.30 | 0.25 | 0.31 | 0.36 | 0.25 | 0.07 | 0.01 | — | — | — |
| Net debt / EBITDA | −2.67 | 1.07 | 0.93 | 8.82 | 4.99 | −5.26 | −26.80 | −113.43 | −54.87 | −64.36 |
| Current ratio | 3.16 | 1.09 | 1.07 | 1.05 | 0.89 | 2.38 | 2.58 | — | — | — |
| Quick ratio | 3.10 | 1.09 | 1.06 | 1.05 | 0.87 | 2.38 | 2.58 | — | — | — |
| Interest coverage | 1.5 | 1.6 | 1.5 | 1.6 | 2.6 | — | — | — | — | — |
| Working capital | $16.77B | $2.05B | $1.05B | $792.3M | −$505.3M | $169.2M | $133.3M | — | — | — |
| Invested capital | −$1.96B | $1.90B | $1.43B | $3.19B | $1.01B | $399.0M | $213.2M | $221.2M | $283.2M | $185.7M |
| Tangible asset value | $928.2M | $743.9M | $556.3M | $496.6M | $247.3M | $231.0M | $230.8M | $239.1M | $230.6M | $232.3M |
| Net current asset value | −$8.88B | $492.9M | $100.3M | $288.0M | −$662.1M | −$3.03B | −$1.94B | — | — | — |
| Graham number | $38.89 | $29.08 | $20.70 | $16.69 | $11.00 | $10.91 | $9.65 | $4.87 | $6.32 | $6.85 |
| Graham net-net per share | −$149.88 | −$145.35 | −$86.38 | −$71.30 | −$33.30 | −$50.00 | −$32.07 | −$14.06 | −$10.28 | −$9.46 |
| Capital allocation | ||||||||||
| Dividends paid | $55.5M | $77.1M | $58.3M | $6.6M | $20.0M | $18.2M | — | — | $20.0M | $20.0M |
| Share buybacks (net) | $44.1M | $19.8M | $3.1M | $7.9M | $0 | — | — | — | — | — |
| Dividend payout ratio | 18.0% | 35.4% | 45.5% | 7.2% | 35.4% | 41.5% | — | — | 114.3% | 97.6% |
| Dividends + buybacks / free cash flow | 15.2% | 8.5% | 8.5% | 6.7% | 4.3% | — | — | — | — | 69.3% |
| Capex / revenue | 0.4% | 0.7% | 0.5% | 0.8% | 0.9% | 0.4% | 0.5% | 0.3% | 0.5% | 0.4% |
| Capex / operating cash flow | 2.0% | 1.7% | 1.6% | 4.2% | 1.6% | — | — | 0.8% | — | 4.2% |
| Capex / depreciation | 0.36 | 0.69 | 0.55 | 0.68 | 0.71 | 0.39 | 0.36 | 0.73 | 1.04 | 0.43 |
| Stock-based compensation / revenue | 1.2% | 1.0% | 0.9% | 1.4% | 0.1% | — | — | — | — | — |
| R&D / revenue | — | — | — | — | — | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% |
| SG&A / revenue | 8.0% | 8.5% | 34.0% | 10.2% | 9.7% | — | — | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 1,036.8 | 1,088.1 | 1,299.3 | 1,740.7 | 931.4 | — | — | — | — | — |
| Days of inventory on hand | 103.3 | 22.6 | 55.1 | 67.6 | 48.0 | — | — | — | — | — |
| Days payables outstanding | 3,882.4 | 1,436.8 | 3,200.2 | 5,795.0 | 1,970.9 | — | — | — | — | — |
| Cash conversion cycle (days) | -2,742.3 | -326.1 | -1,845.8 | -3,986.7 | -991.6 | — | — | — | — | — |
| Receivables turnover | 0.35 | 0.34 | 0.28 | 0.21 | 0.39 | — | — | — | — | — |
| Payables turnover | 0.09 | 0.25 | 0.11 | 0.06 | 0.19 | — | — | — | — | — |
| Inventory turnover | 3.53 | 16.14 | 6.62 | 5.40 | 7.61 | — | — | — | — | — |
| Asset turnover | 0.12 | 0.14 | 0.14 | 0.11 | 0.19 | 0.24 | 0.28 | 0.31 | 0.29 | 0.29 |
| Average receivables | $10.31B | $8.63B | $8.37B | $5.61B | $2.17B | — | — | — | — | — |
| Average payables | $9.76B | $6.33B | $5.78B | $4.97B | $3.29B | — | — | — | — | — |
| Average inventory | $259.8M | $99.6M | $99.6M | $58.0M | $80.1M | — | — | — | — | — |
| Intangibles / total assets | 1.0% | 1.0% | 1.2% | 1.2% | 4.4% | 5.6% | 7.2% | 10.2% | 13.1% | 12.5% |
Computed from MRX's annual financial statements (latest annual report filed March 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
MRX valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Marex traded at 9.5 times earnings. Based on the latest twelve months, the trailing P/E is 14.2 and the forward P/E is 7.2. Marex earned a return on equity of 27.5% in fiscal 2025. It ended the year with $10.2 billion of debt and $13.5 billion in cash and short-term investments, a net cash position of $3.2 billion. It returned $99.6 million to shareholders: $55.5 million in dividends and $44.1 million in share buybacks, 15% of free cash flow. The share count rose 25.6% from 60.6M to 76.1M over 9 years.
See the MRX income statement, the MRX chart for price history, or the MRX stock overview for the latest quote and news.
MRX key metrics FAQ
What is Marex's P/E ratio?
Marex's trailing P/E ratio is 14.2 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 7.2. At the end of fiscal 2025 it was 9.5.
What is Marex's return on equity?
Marex's return on equity (ROE) was 27.5% in fiscal 2025: net income of $308.2 million on average shareholders' equity of $1.1 billion.
How much debt does Marex have?
Marex had total debt of $10.2 billion at the end of fiscal 2025, a debt-to-equity ratio of 8.10 and more cash than debt.
What is Marex's dividend yield?
Marex's forward dividend yield is 0.86%. Marex paid $55.5 million in dividends in fiscal 2025 ($0.73 per share), a payout ratio of 18.0%.
Does Marex buy back its shares?
Yes. Marex spent $44.1 million on net share repurchases in fiscal 2025 Shares outstanding changed +1.1% over the year, to 76.1M..
What is Marex's free cash flow yield?
Marex generated $654.4 million of free cash flow in fiscal 2025, a free cash flow yield of 22.4% on its market value at year-end ($2.9 billion).
What is Marex's current ratio?
Marex's current ratio was 3.16 at the end of fiscal 2025: current assets were 3.16 times current liabilities.